Healthcare Realty Trust (FRA:HT0) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


FRA:HT0 Healthcare Realty Trust Inc FRA:HT0
68 GF Score
Price €17.80
GF Value €13.97
! 9 Warning Signs
View Full Analysis

What is Healthcare Realty Trust Research & Development?

Healthcare Realty Trust FRA:HT0 +0.56% 68 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:HT0 with a GF Score™ of 68/100 and a GF Value™ of €13.97. The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Healthcare Realty Trust's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Healthcare Realty Trust  (FRA:HT0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Healthcare Realty Trust Research & Development Related Terms

Healthcare Realty Trust Research & Development Historical Data

* Premium members only.

The historical data trend for Healthcare Realty Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthcare Realty Trust Research & Development Chart

Healthcare Realty Trust Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Healthcare Realty Trust Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:HT0
68GF Score
Healthcare Realty Trust Inc FRA:HT0
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthcare Realty Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Healthcare Realty Trust (FRA:HT0) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Healthcare Realty Trust and its competitors.
Is Healthcare Realty Trust's Research & Development too high?
Healthcare Realty Trust's current Research & Development is €0.0 Mil. Overall, Healthcare Realty Trust has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Healthcare Realty Trust's Research & Development compare to SBRA and CTRE?
Healthcare Realty Trust's Research & Development of €0.0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Healthcare Realty Trust and its competitors. Healthcare Realty Trust's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare Realty Trust stock overvalued right now?
Healthcare Realty Trust (FRA:HT0) has a current Research & Development of €0.0 Mil. The stock's GF Value™ is €13.97, compared to a current price of €17.80 — trading 27.4% above its estimated fair value. The current Research & Development is €0.0 Mil. Healthcare Realty Trust's overall GF Score™ is 68/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Healthcare Realty Trust (FRA:HT0), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthcare Realty Trust (FRA:HT0) Overvalued in 2026?

Based on GuruFocus' analysis, Healthcare Realty Trust stock appears to be overvalued. The current stock price of €17.80 is trading 27.4% above its estimated GF Value™ of €13.97.

Key valuation signals for FRA:HT0:

  • Research & Development: €0.0 Mil
  • GF Value™: €13.97 vs. price of €17.80 (27.4% above fair value)
  • GF Score™: 68/100 with 9 warning signs

No single metric tells the full story. See the FRA:HT0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healthcare Realty Trust Business Description

Industry Real EstateREITs
Other Exchanges HR:USAHT0:Germany
Address 3310 West End Avenue, Suite 700, Nashville, TN, USA, 37203
Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.
68GF Score

Get the complete analysis for FRA:HT0

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.80
Price
€13.97
GF Value